Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/1998
04/01/1998EP0831836A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
04/01/1998EP0831830A1 Imidazole compounds
04/01/1998EP0831827A1 Novel formulations for transdermal delivery of pergolide
04/01/1998EP0831812A2 Methods and compositions for stimulating neurite growth
04/01/1998EP0831810A1 Transdermal formulation comprising ropinirole
04/01/1998EP0831800A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
04/01/1998EP0831799A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
04/01/1998EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
04/01/1998EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
04/01/1998EP0453515B1 Composition for treatment of senile dementia
04/01/1998CN1177498A Chinese traditional medicine for treating epilepsy
04/01/1998CN1177495A Xueguiling analgesic
03/1998
03/31/1998US5734059 Production intermediate and process for producing pyridine derivative
03/31/1998US5734051 8-substituted xanthine derivatives and method of use thereof
03/31/1998US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide)
03/31/1998US5733936 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
03/31/1998US5733930 Topical gel; anaesthesia
03/31/1998US5733926 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
03/31/1998US5733912 Nervous system disorders in nerve cells
03/31/1998US5733910 Pyridazinedione compounds useful in the treating neurological disorders
03/31/1998US5733908 Useful in the treatment of parkinson's disease and schizophrenia
03/31/1998US5733881 Analgesics, immunosuppressants
03/31/1998US5733875 Epilepsy
03/31/1998US5733867 Cholecystokinins and gastrin antagonist
03/31/1998US5732717 Administering 4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine
03/31/1998CA2134889C Calcium channel blocking polypeptides from filistata hibernalis
03/31/1998CA2116356C Antimuscarinic bronchodilators
03/31/1998CA1339791C Human nerve growth factor
03/27/1998CA2216479A1 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia
03/26/1998WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012190A2 Phenoxathiin derivatives as inhibitors of monoamine oxidase
03/26/1998WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
03/26/1998WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011897A1 Combination therapy for treatment of psychoses
03/26/1998WO1998011893A1 Olanzapine dihydrate d
03/26/1998WO1998011890A1 Use of benzopyranols to treat neurological disorders
03/26/1998WO1998011882A1 Pharmaceutical compositions and methods
03/26/1998WO1998011881A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications
03/26/1998WO1997048724A3 Human metabotropic glutamate receptor
03/26/1998WO1997043272A3 Benzofurans and benzopyrans as chronobiological agents
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266681A1 Use of benzopyranols to treat neurological disorders
03/26/1998CA2266496A1 Pharmaceutical compositions and methods
03/26/1998CA2265943A1 Phenoxathiin derivatives as inhibitors of monoamine oxidase
03/26/1998CA2265896A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998CA2265894A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications
03/25/1998EP0831097A2 Olanzapine dihydrate D
03/25/1998EP0830864A1 Combination therapy for treatment of psychoses
03/25/1998EP0830861A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
03/25/1998EP0830858A1 Formulation comprising coated olanzapine particles
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830369A1 Novel nor-pregnanes for inducing hypothalamic effects
03/25/1998EP0830348A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
03/25/1998EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
03/25/1998EP0830136A1 New cryptophycins from synthesis
03/25/1998EP0801646A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
03/25/1998CN1177381A Process for producing phosphatidylserines having polybasic unsaturated fatty acid and as side chain
03/25/1998CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof
03/25/1998CN1177349A Certain 4 -aminomethyl -2 -substituted imidazole derivatives and 2 -aminomethyl -4 -substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1037841C Process for preparing substituted 4 -phenyl -4 - piperidinecarboxamide having local anaesthetis and analgestic effect
03/24/1998US5731432 Inhibitors of adenosine monophosphate deaminase
03/24/1998US5731352 Therapy for disorders of the melatoninergic system
03/24/1998US5731349 Glycine
03/24/1998US5731348 Alkylcarboxy amino acids-modulators of the kainate receptor
03/24/1998US5731340 Dietetics; antidiabetic agents
03/24/1998US5731337 Conformationally rigid bicycle and adamantane derivatives useful as α2
03/24/1998US5731336 Method for treating multiple sclerosis
03/24/1998US5731335 Nervous system disorders; stroke; antiischemic agents; cognition activators
03/24/1998US5731333 Learning and memory enhancement, antidepressants
03/24/1998US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens
03/24/1998US5731331 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
03/24/1998US5731322 Octahydro-1H-pyrrolo 3,2-g!and 2,3-g!isoquinoline derivatives
03/24/1998US5731319 Antiallergens; antihistamines
03/24/1998US5731313 Use of anthracyclinone derivatives in amyloidosis
03/24/1998US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/24/1998US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
03/24/1998US5731000 Stabilized pharmaceutical composition containing bupropion
03/24/1998US5730998 Administering substance p antagonist
03/24/1998US5730985 Methyl ecgonine phenylphosphonate as chemical intermediate of cocaine
03/24/1998CA2129037C Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
03/20/1998CA2185950A1 Process for preparing intermediates for thrombin inhibitors
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011213A1 Method for treating amyotrophic lateral sclerosis
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011135A1 A taxol-like protein (talp) and process for preparing the same
03/19/1998WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011119A1 Novel pyranoside derivatives
03/19/1998WO1998011110A1 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998011090A2 3-alkyl-3-phenyl-piperidines
03/19/1998WO1998011086A1 Chromone derivatives and nerve cell death inhibitors containing the same
03/19/1998WO1998011075A1 Pyrazinones and triazinones and their derivatives thereof
03/19/1998WO1998011068A1 D4 receptor selectivity piperazine derivatives